Text Size
22 studies found for:    " August 01, 2007":" August 31, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
" August 01, 2007":" August 31, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM5)
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome
Interventions: Drug: Vicriviroc;   Drug: Placebo
2 Completed Feasibility and Pilot Efficacy of Flash-heated Breast Milk to Reduce Maternal-to-Child-Transmission of HIV in Tanzania
Condition: HIV Infections
Intervention: Procedure: Infant feeding counseling that includes Flash-heat
3 Completed Testing of INSTI™ HIV-1 Antibody Test Kit in Volunteer Subjects at Risk for HIV Infection
Condition: HIV Infections
Interventions: Other: Behavioral counseling;   Device: HIV-1 Antibody Test Kit
4 Unknown † Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients
Condition: HIV Infections
Interventions: Genetic: GX-12;   Drug: HAART
5 Completed Integrase Inhibitor (MK-0518) Viral Decay
Condition: HIV Infections
Interventions: Drug: Raltegravir (MK0518);   Drug: Placebo;   Procedure: Leukopheresis;   Procedure: Sigmoid Biopsy
6 Terminated TMC114-C227: A Study to Evaluate the Effectiveness and Safety of TMC114 (Darunavir) With a Low Dose of Ritonavir as Monotherapy (no Other Anti-HIV Drugs Will be Given) in Patients Who Have Never Been Treated With Antiretrovirals (Anti-HIV Drugs) Previously
Condition: HIV Infections
Intervention: Drug: TMC114 (darunavir) / ritonavir
7 Completed Adherence and Risk Behaviour in Patients With HIV Infection Receiving Antiretroviral Therapy
Condition: HIV Infections
Intervention:
8 Terminated A Study to Determine the Best Dose of Antivirals in Patients With Both TB and HIV
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: efavirenz or nevirapine
9 Completed Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*
Condition: HIV Infections
Interventions: Drug: matching placebo;   Drug: Bevirimat
10 Completed DDI HV (ATV - Merck)
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Atazanavir;   Drug: Atazanavir + Raltegravir
11 Active, not recruiting Autologous Dendritic Cell Vaccine in HIV1 Infection
Condition: HIV Infections
Intervention: Biological: Autologous HIV-1 ApB DC Vaccine
12 Unknown † Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies
Conditions: HIV Infections;   Cancer, Second Primary
Interventions: Dietary Supplement: Probiotic Yogurt B: with various micronutrients;   Dietary Supplement: Probiotic Yogurt A: Kaiser micronutrients;   Dietary Supplement: Probiotic yogurt C: with basic micronutrients;   Dietary Supplement: Probiotic Yogurt D: Placebo -- no added micronutrients
13 Completed
Has Results 		A Study to Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN)
Condition: Human Immunodeficiency Virus - Type 1
Interventions: Drug: Darunavir (DRV);   Drug: Ritonavir (rtv)
14 Completed
Has Results 		Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load
Condition: HIV Infections
Interventions: Drug: Raltegravir (MK-0518);   Drug: Placebo
15 Completed
Has Results 		RAL-eve Study: Raltegravir Substitution Study
Condition: HIV Infections
Intervention: Drug: Raltegravir
16 Completed Pilot Study of Pyridostigmine Upon Immune Activation in HIV-1 Patients Who Have an Inadequate Immune Response
Condition: HIV Infections
Intervention: Drug: Pyridostigmine tablets
17 Terminated
Has Results 		Comparison of TPV/r to DRV/r in Triple Class Experienced Patient With Resistance to > 1 PI
Condition: HIV Infections
Interventions: Drug: Tipranavir;   Drug: Darunavir;   Drug: Ritonavir
18 Recruiting Observational Study of HIV Infected Women Previously Enrolled in Other Microbicide Trials
Condition: HIV Infections
Intervention:
19 Completed Occurrence of Pneumocystis Pneumonia in HIV-Infected Patients and the Interference of the HAART
Condition: HIV
Intervention:
20 Withdrawn Sunitinib Malate in Treating East African Patients With Kaposi Sarcoma
Conditions: AIDS-related Kaposi Sarcoma;   Classic Kaposi Sarcoma
Interventions: Drug: sunitinib malate;   Procedure: laboratory biomarker analysis;   Procedure: pharmacological study
To Top

Previous Page Studies Shown (1-20) Next Page (21-22) Show next page of results
† Indicates status has not been verified in more than two years